Gastrointestinal bleeding localisation
When bleeding inside the gut is hard to pin down, labelling a patient's own red blood cells with a radioactive tracer and watching where blood leaks into the bowel over several hours can find the source, even if the bleeding comes and goes.
Overview
Gastrointestinal bleeding scintigraphy (GIBS) detects and localises active bleeding into the bowel lumen using the patient's own red blood cells labelled with Tc-99m, exploiting the tracer's long intravascular half-life to allow continuous imaging of the entire gastrointestinal tract for many hours, unlike single-timepoint techniques such as CT angiography. It is used for both overt bleeding (melena, haematochezia) and, less often, occult bleeding, and is particularly valuable because gastrointestinal bleeding is frequently intermittent, so a technique that can watch continuously for extended periods has a real advantage over a snapshot study.
The SNMMI/ACNM (and previously SNMMI/EANM) procedure standard specifies an administered activity of 555-1,110 MBq of Tc-99m-labelled red blood cells (labelled in vitro, in vivo, or by a modified in vivo technique), dynamic imaging beginning immediately after injection at no more than one frame per 60 seconds, and a minimum of 60 minutes of initial imaging if no bleeding is seen, extendable up to 24 hours by rescanning if there is ongoing clinical suspicion. The diagnostic criteria require all three of: focal activity appearing outside expected blood-pool structures, a change in the intensity of that activity between images, and a pattern of movement consistent with peristalsis through the bowel - meeting only one or two of these criteria is not sufficient to call a positive study.
Because the test can detect bleeding rates as low as roughly 0.1 mL per minute in clinical use, it is generally more sensitive than catheter angiography (which typically needs faster bleeding, around 0.5-1 mL/min, to show extravasation) and is often used to decide whether, and where, to proceed to angiography and embolisation or, alternatively, direct the endoscopist or surgeon to the likely segment of bowel. It requires no patient preparation, has minimal radiation burden relative to repeated CT, and can be safely performed in haemodynamically unstable patients provided appropriate monitoring is in place.
State of the art
- The SNMMI Procedure Standard/ACNM Practice Guideline for Gastrointestinal Bleeding Scintigraphy 3.0 (2025) is the current version, building on the 2014 SNMMI/EANM standard, and formalises the three-part positivity criteria and updated paediatric weight-based dosing.
- Tc-99m-RBC scintigraphy remains more sensitive for intermittent, low-rate bleeding than CT angiography or catheter angiography, which need a higher active bleeding rate to show extravasation at the single moment of image acquisition.
Gastrointestinal bleeding is a common reason for hospital admission; lower gastrointestinal bleeding alone accounts for a large share of gastroenterology-related emergency presentations, and GIBS is one of the most frequently requested non-oncological nuclear medicine studies performed on an urgent basis.
Tc-99m-labelled red blood cell scintigraphy, imaged dynamically for a minimum of 60 minutes and extendable to 24 hours, read as positive only when focal extravascular activity changes in intensity and moves in a bowel pattern.
Catheter angiography with embolisation, or surgery, targeted to the segment identified on scintigraphy.
Subtypes & biomarkers
topHow often this target appears
Dated changes read from the records linked to this indication: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
All 1 changes by month →What is in development for Gastrointestinal bleeding localisation, drawn from the whole corpus: 0 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
Nothing recorded in development for this cancer yet.
Open problems and what is being done
Serial intermittent static imaging is explicitly discouraged in favour of continuous dynamic acquisition, but adherence to this varies across centres with older equipment or workflow constraints.
The scan localises bleeding to a general bowel region rather than a precise anatomical point, so it complements rather than replaces endoscopy or angiography for definitive treatment planning.
In vivo versus in vitro red blood cell labelling technique affects labelling efficiency and image quality; the highest-efficiency in vitro kit-based labelling is not universally available.
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Direct links plus the targets, companies, and technologies of this cancer's products.
isotopes
1technologies
1Latest papers
topQuery for this indication: (TITLE:"Gastrointestinal bleeding localisation" OR ABSTRACT:"Gastrointestinal bleeding localisation") AND (treatment OR therapy OR trial OR survival OR diagnosis). Results are unfiltered search hits about Gastrointestinal bleeding localisation, not a curated reading list.
Similar pages
not linked directly; found by shared links- IndicationSuspected upper urinary tract obstruction
Shares SPECT & bone scan, Technetium-99m and the tag dynamic imaging.
- AgentTechnetium-99m exametazime (brain perfusion)
Shares SPECT & bone scan, Technetium-99m.
- TechnologyMolybdenum-99/technetium-99m generators
Shares SPECT & bone scan, Technetium-99m.
- IndicationFunctional assessment of thyroid nodules
Shares SPECT & bone scan, Technetium-99m.
- IndicationPulmonary embolism: ventilation/perfusion imaging
Shares SPECT & bone scan, Technetium-99m and the tag emergency.
- IsotopeKrypton-81m
Shares SPECT & bone scan, Technetium-99m.
- AgentTechnetium Tc-99m PSMA agents (PSMA-I&S)
Shares SPECT & bone scan, Technetium-99m.
- AgentTechnetium Tc-99m medronate (MDP)
Shares SPECT & bone scan, Technetium-99m.